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Abstract 
For mo5coring of recombinant human antithrombin III during cell culture processes and subsequent purification 
steps a rapid method for quantitative determination was developed. The need for the introduction of this rapid 
method came from the limited availability of a quantitative enzyme-linked immunosorbent assay (ELBA) and the 
very time-consuming ELISA procedure. The developed method is based on reversed-phase high-performance 
liquid chromatography using a C, column. The separation by gradient elution using water and acetonitrile takes 
less than 20 min even when complex samples, such as serum containing cell culture samples, have to be analyzed. 
Automation and a high sample throughput are possible with this reliable method. If necessary, insulin, transferrin 
and albumin can also be quantified with minor changes of the elution profile. 
1. Introduction 
Antithrombin III (ATIII) is a plasma glyco- 
protein which is the major physiological reg- 
ulator of several activated coagulation factors 
including thrombin, factor IXa, Xa, XIa, XIIa. 
AT111 is a member of the serine protease inhib- 
itor (SERPIN) family with a molecular mass of 
about GO 000 and about 15% carbohydrate con- 
tent. The polypeptide chain consists of 432 
amino acids and three disulphide bridges. The 
carbohydrate structure is split into four bianten- 
nary asparagine-linked chains. 
ATIII is of some clinical importance for in- 
dividuals with acquired or inherited deficiency of 
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AT111 activity who suffer from a risk of venous 
thrombosis and pulmonary embolism [I]. In 
these cases a sufficient supply of pure AT111 can 
be necessary. 
The protein can be purified from human 
plasma [2,3]. But, from the view of product 
safety and possible virus contamination (HIV, 
hepatitis) ATIII can also be produced by recom- 
binant DNA technology. For this reason the 
human AT111 cDNA was isolated and expressed 
among others, in Chinese hamster ovary (CHO) 
cells. DHFR (dehydrofolate reductase)-deficient 
CHO celis were cotransfected with human AT111 
cDNA and mouse DHFR cDNA [4]. Gene-am- 
plified positive clones were obtained under selec- 
tion pressure of increasing concentrations of the 
DHFR inhibitor MTX (4-amino-lo-methyl folic 
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acid, methotrexate). The CHO cells release the 
product into the surrounding medium. From that 
supernatant ATIII can be purified, especially if 
cells are cultured under serum-free conditions. 
On the basis of the low expression level of the 
CHO cells it is necessary for the production of 
sufficient quantities of ATIII to use efficient 
bioreactor and purification systems as well. 
In both cases a permanent and rapid control of 
product concentration and purity is required 
during the whole process. For monitoring of 
product concentration during fermentation an 
analytical tool based on enzyme-linked immuno- 
sorbent assay (ELISA) is available. The main 
disadvantages of ELISA methods are long prep- 
aration and measuring times and a high margin 
of error. During product purification the con- 
tinual review of the decrease of impurities is very 
important. Eiectrophoretic techniques for ana- 
lytical protein separations are state of the art. In 
spite of many advances in this field by precast 
ultrathin gels and automatization this technique 
is very time consuming. To overcome both 
problems of ELISA and electrophoresis tech- 
niques as well, we employed RP-HPLC as a 
rapid tool for controlling AT111 concentrations in 
cell culture supernatant and also for detection of 
main impurities during purification. 
2. Experimental 
2.1. Cell cdture 
A recombinant Chinese hamster ovary 
(rCH0) cell line (SS3-A2) producing human 
active recombinant ATIII (rATII1) [4] was culti- 
vated in a 2-l bench-scale stirred tank bioreactor 
(Biostat MD2, B. Braun Biotech International, 
Melsungen, Germany). The cells were prop- 
agated in a serum-free standard medium (Dul- 
becco’s Modified Eagle Medium and Ham’s Fi2, 
1:l mixture) (Gibco, Paisley, UK) [5] sup- 
plemented with ethanolamine (150 pmol/l), 
glucose (5.5 mmol/l) and amino acids in various 
concentrations. As protein additives the medium 
contained human transferrin (HT) (10 mg/l) 
(Behringwerkc, Marburg, Germany), bovine in- 
sulin (IN) (10 mg/l) (Sigma, Deisenhofen, Ger- 
many) and lipoproteins (Excyte I, Bayer Diag- 
nostic, Munich, Germany) (1 ml/l). 
The reactor was equipped with a fixed aeration 
basket carrying 10 m of silicone tubing for 
bubble free aeration [6]. The reactor vessel was 
connected to two reservoirs via two peristaltic 
pumps (101 UR/32, Watson Marlow, Falmouth, 
UK). One of the reservoirs was filled with 
complete serum-free medium, the other with a 
5-fold concentrate of medium substrates (glu- 
cose, amino acids, etc.). p0, in the reactor was 
monitored with a p0, probe (Ingold, Steinbach, 
Germany) and controlled by feeding nitrogen or 
oxygen, respectively, into the continuous aera- 
tion stream of air. pH was monitored with a pH 
electrode (Ingold, Steinbach, Germany) and 
controlled by feeding CO, into the aeration 
stream. The bioreactor parameters were set as 
follows: p0, 40% air saturation, pH 7.1, stirrer 
speed 65 rpm, temperature 37°C. The seed cells 
were prepared in T-flasks and spinner systems. 
At the end of the cultivation the culture broth 
was stored at 4°C overnight to let the cells settle. 
Then, the supernatant was decanted and 0.45- 
pm filtrated before purification to remove the 
remained particles. 
2.2. Do wnstremz processing 
The purification of rATI was done by a three 
step procedure of ion exchange c:,iromatography, 
affinity chromatography and gel filtration. In 
order to bind rATI to the anion exchanger the 
conductivity of the supernatant had to be re- 
duced from 13 mS/cm to about l-l.5 mS/cm by 
diafiltration with a M’, 10 000 membrane 
(SlOYlO, Amicon, Berverly, MA, USA). After 
adjusting the pH to 7.0, the supernatant first was 
filtrated (0.2 pm) to remove particles and then 
passed through a preparative membrane ion-ex- 
change unit. The ion-exchange step was per- 
formed with a strongly basic Sartobind mem- 
brane ion-exchange module with a filtration area 
of 2400 cm’, which was kindly supplied by 
Sartorius (Gettingen, Germany). The procedure 
for this step is published in detail elsewhere [7]. 
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‘lhe affinity matrix was heparin (Sigma) coupled 
to controlled pore glass (Schott, Mainz, Ger- 
many). The coupling procedure is described 
elsewhere [8]. A 50-ml volume of heparin-con- 
trolled pore glass was used in a XK 50/30 
column (Pharmacia Biosystems, Freiburg, Ger- 
many). Final purification w’as carried out using a 
preparative gel permeation column (Superdex 
200 PG; Pharmacia Biosystems) with a .gei voi- 
ume of 600 ml. 
Buffers: for the basic membrane ion exchanger 
a buffer system of (A) 20 mM Tris - HCI (pH 7) 
and (B) 20 mM Tris - HCI-250 mM NaCI (pH 7) 
was used, For the affinity chromatography the 
buffer system was (A) 20 mM 4-(2-hydroxy- 
ethyl)-l-piperazine-ethanesuiphonic acid 
(HEPES)-150 mM NaCi (pH 5.8) and (B) 20 
mM HEPES-2.5 M NaCl (pH 7). For gel 
permeation a 20 mM sodium phosphate-150 mM 
NaCl (pH 7) buffer was used. 
2.3. Analytical methods 
rATIII concentrations were determined by 
HPLC. The chromatographic system was a fully 
computer-controlled Kontron HPLC workstation 
with DS450-MT2 software (Kontron, Neufahrn, 
Germany) consisting of two pumps type 420, a 
high-pressure mixing chamber, an autosampler 
type 465 (all Kortron) and a spectrofluorimeter 
RF 551 (Shimadzu, Duisburg, Germany). The 
spectrofluorimeter was set to an excitation wave- 
length of 280 nm and emission was monitored at 
340 nm. The HPLC column used in this study 
was a 50 mm x 4.6 mm I.D. C, reversed-phase 
column (type 214.TP5405, Vydac, Hesperia, CA, 
USA) with 5 pm particle size and 30 nm pore 
size. For the separation a binary gradient (gra- 
dients are discussed below in detail) was used 
with following eiuents: eluent A: water-acetoni- 
trile (87.5:12.5, vlvj with 0.01% trifluoroacetic 
acid (TFA); ciuent B: acetonitriie-water (70130, 
v/v) with 0.08% TFA. Pure water was prepared 
with a Miiii-Q system (Millipore, Eschborn, 
Germany), acetonitrile was of HPLC quality and 
TFA was of quality used for protein sequencing 
(both Merck, Darmstadt, Germany). 
To control and verify the HPLC data rATI 
concentrations in the samples were also deter- 
mined by a kinetic sandwich ELISA method 
(Behringwerke). It was necessary to dilute sam- 
ples 1:50 to 1:500 (for fermentation samples) or 
higher (for samples from purification steps) to 
have the correct scale range of the ELISA. 
Purity was determined by sodium dodecyi 
sulphate-poiyacryiamide gel clectrophoresis 
(SDS-PAGE) [9] automatically (Phast-System, 
Pharmacia Biosystems) using silver staining [lo]. 
The silver-stained gels were scanned using an 
Epson flat bed scanner GTGOOO and the Gei- 
Image 1DEVA software (Pharmacia Biosys- 
terns). 
2. Results 
3.1. Calibration 
For quantification of both proteins rATIII and 
HT as well response factors corresponding to 
integrated peak area were used. The response 
factor for rATI was investigated in the foiiow- 
ing way. rATI was purified from serum-free 
supernatant to a purity higher than 99% with 
methods described above. The final eiution from 
the gel permeation step was quantified with the 
ATIII-ELISA at several dilution steps. Then, 
several calibration runs with different dilutions 
of that solution were made by HPLC. From this 
calibration curve &he response factor for rATII.1 
was calculated. This procedure was necessary 
because purified human AT111 could not be 
purchased in correct quality and sufficient 
amounts. The response factor for HT was ob- 
tained by analyzing several dilutions of a stock 
solution of HT which was also iised for suppie- 
mentation of the serum-free medium. For 
rATIII an on-column amount in the range from 
0.1 to 1 pg AT111 gave a linear response with a 
response factor of 23.93 units per /-Lg (relative 
peak area). A linear response for an on-column 
range of 0.1 to 0.5 kg with a response factor of 
25.65 units per pg could be determined for HT. 
The range for HT had not to be extended to 
higher amounts because maximal concentration 
of HT in fermentation and purification samples 
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Fig. 1. Calibration curves for recombinant h*rman antithrom- 
bin III (0) and human transfcrrin (0). An on-column 
amount from 0.1 to 1 pg ATIII gave a linear response with a 
response factor of 23.93 units per pg (relative peak arca). A 
linear response for an on-column range of 0.1 to 0.5 pg with 
a response factor of 25.65 units per pg could bc determined 
for HT. 
never exceeded this range. In Fig. 1 rhe cali- 
bration curves for rATII1 and HT are shown. 
The reproducibility of the method was evaluated 
by repeated analyses of a mixture of an aqueous 
solution of HT (10.0 mg/l) and ATIII (16.65 
mg/l). The solution was injected 14 times show- 
ing a result for HT of 10.31 -t 0.63 mg/l and for 
AT111 of 16.48 + 0.66 mg/l, respectively. 
3.2. Separation 
For the separation of rATI and HT on the 
RP column a special elution profile had to be 
developed. The proteins occurring in fresh 
serum-free medium are insulin, human trans- 
ferrin, small amounts of lipoprotein and some- 
times an additional amount of bovine serum 
albumin up to 1 g/l. In cell culture supernatant 
rATI and smaller amounts of some other 
proteins formed by secretion or cell lysis are also 
present. Because of the rapid degradation of 
insulin in cell culture broth [llj, this protein can 
only be detected in the supernatant in very small 
amounts which cannot be quantified. 
In order to perform a good resolution for 
rATI quantification the following profile was 
used: 0 to 1 min 100% eluent A, 1 to 5 min 
linear gradient 0 to 48% eluent B, 5 to 12.5 min 
linear gradient 48 to 65% eluent B, 12.5 to 14 
min linear gradient 65 to 100% eluent B, 3 min 
100% eluent B. Fig. 2 shows a typical chromato- 
gram with this multi-step elution profile resulting 
in a satisfactory separation. 
rATI was also quantified in cell culture 
supernatant containing up to 10% fetal bovine 
serum (FBS). In this case the elution profile was 
changed regarding the great variety of proteins 
present in very different concentrations. The 
total amount of proteins in medium containing 
10% FBS is about 4 g/l in respect to serum-free 
medium with about 30 mg/l as described above. 
In Fig. 3 the chromatograms of separations of 
fresh medium with 5% FBS and supernatant of 
ATIII-CHO cells at the end of a batch are 
shown. The rATI peak corresponds to a con- 
centration of 20 mg/l. 
A column regeneration step was performed 
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Fig. 2. Chromatogram of a protein separation from cell 
culture mediurr with a multi-step elution profile. I-‘eaks: 
1 = insulin (injected amount 0.75 pg); 2 = human transferrin 
(0.2 pg); 3 = bovine albumin (0.2 pg); 4= recombinant 
human antithrombin III (0.33 pg). The following elution 
profile was used: 0 to 1 min 100% eluent A, 1 to 5 mitt linear 
gradient 0 to 48% eluent B, 5 to 12.5 min linear gradient 48 
to 65% etuent B, 12.5 to 14 min linear gradient 65 to 100% 
eluent B, 3 min 100% eluent B. 
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F:,g. 3. Elution profile of protein separations of cell culture medium and cell culture supernatant each containing 5% fetal bovine 
serum. (Left) Fresh medium before cultivation; (right) cell culture medium at end of a CHO batch cultivation. The peak marked 
in black corresponds to an AT111 concentration of 20 mgli. 
every 5 to 15 samples depending on total protein 
content of the samples. The column was washed 
with buffer B for 10 min and reequilibrated with 
one gradient e!ution without injection. Prior to 
injection each sample was passed through a 0.45- 
,zrn membrane filter to remove particles. Using 
these precautions the lifetime of the column 
could be exceeded to more than 500 sample 
runs. During this time the elution qua%j; varied 
only slightly with irregularities during elution 
buffer preparation. After each buffer change the 
system was calibrated. The calibration data were 
compared with previous calibrations and stored 
for !ater coiumn evaluation. 
3.3. Monitoring a fermentation 
A 18-day fed batch process was monitored for 
product (rATII1) concentration with both ana- 
lytical methods, ELISA and RP-HPLC. Fig. 4 
shows the time course of this cultivation. The 
cells were seeded at a cell density of 1.8 - 10’ 
celis/ml in 0.5 1 reactor volume and cultivated in 
batch mode for four days until the cell growth 
rate decreased. A cell density of 7. lo5 cells/ml 
was reached. Then, the fed batch procedure was 
started by feeding complete serum-free medium 
into the reactor vessel. First, the cell growth rate 
increased, but three days later (days 7 and 8) cell 
growth stopped again indicating limitation of 
nutrients. Therefore, at day 8, the second feed- 
ing stream of a 5-fold substrate enriched medium 
was activated. Cells growth started again, reach- 
ing a final amount of 1.3 - 10’ cells in the bio- 
reactor. This level of cells occurred because of 
nutrient limitation (data not shown). The feeding 
rate of medium and concentrate was not high 
enough to satisfy the cells for further cell growth. 
Nevertheless, the production of rATII1 never 
stopped, reaching a final amount of about 90 mg 
rATI in the bioreactor which corresponds to a 
concentration of 52 mg rATIII per litre. From 
Fig. 4 it can be seen that the AT111 measure- 
ments with RF-HPLC and ELISA correlate very 
well. Only at higher concentrations the values 
differed considerably which can be explained by 
214 H. Biintcmeyer et al. I J. Chromatogr. B 662 (1994) 209-216 
80 
60 
500 
0 
E 
2 
P 
0 2 4 6 8 10 12 14 16 18 
Time [days] 
Fig. 4. Time course of a fed batch cultivation process of CHO cells producin, 0 rATIlL W =Total cell conccntralion in the 
biorcactor; 0 = AT111 amount in the biorcactor Jctcrmincd wi!h RP-HPLC; 0 = ATlIi amount analyzed with ELlSA method; 
solid lint = cumulative feeding volume of complctc medium; broken lint = cumulative feeding volume of concentrated medium. 
the incorrectness of the ELISA method using 
higher predilutions for increasing concentrations. 
For the RP-HPLC it was not necessary to pre- 
pare the samples in any way cxccpt cc!1 removal. 
Cell free supernatant was applied directly to the 
HPLC column. That made the use of RP-HPLC 
determination much more faster and much easier 
than the ELISA method. 
3.4. Motlitoritg tile downstream processing 
Table 1 shows a comparison between RP- 
HPLC and gel electrophoresis methods for the 
determination of total protein content after the 
Table 1 
Downstream processing of rATI of a serum-free cultivation 
subsequent process steps. After reducing the 
ionic strength by diafiltration rATIII was rapid 
concentrated by a strong basic membrane ion- 
exchange step to reduce the water. During this 
step HT concentration was reduced from 23.1 to 
5.1% total protein content (measured by RP- 
HPLC). But other proteins, especially in the 
low-molecular-mass area, were concentrated. 
The next purification step of rATI was carried 
out by affinity chromatography with heparin 
coupled to controlled pore glass 181. The purity 
increased in this step f&m 58.2 to 83.4% total 
protein content. The concentration of rATIII in 
the eluate increased to 1.3 g/l. The preparative 
Method AT III (%) HT (%) Others (%) 
RP-HPLC Gel-Image RP-HPLC Gel-Image RP-HPLC Gel-Image 
Biorcactor 57.2 n.d. 23.1 n.d. 19.7 n.d. 
Membrane ion exchange 58.2 n.d. 5.1 n.d. 36.7 n.d. 
Heparin affinity chromatography 83.4 72.7 3.9 3.4 12.7 23.9 
Gel permeation 100 100 0 0 0 0 
The total protein content after the subsequent purification steps is shown, determined by RP-HPLC and in comparison to gel 
electrophorcsis and scanning with Gel-Image system; n.d. = not determined. 
H. Biintemeyer et al. I J. Chromatogr. B 662 (1994) 209-216 215 
gel permeation step led to a purity of 100%. is reduced to a duration of about 25 min per 
Contaminants were neither detected by gel elec- sample. Recause of this fast availability of ana- 
trophoresis nor by RP-HPLC. Fig. 5 shows the lytical results the development of new purifica- 
eluates of the different purification steps on a tion methods is simplified. Chromatographic 
SDS-polyacrylamide gradient gel (S-25%) de- results such as capacity, concentration factor and 
tected with a modified silver stain under unre- purity are now available half an hour after each 
duced conditions. purification step. 
The advantage of RP-HPLC detection of 
r.ATIII during downstream processing is the 
rapidity and the possibility of detection and 
quantification of impurities. The detection limit 
of the employed gel electrophoresis methods 
with silver staining is 0.1 ng per lane [12] and for 
routine analysis > 1 ng/lane whereas with RP- 
HPLC an on-column amount of approximately 
100 ng can be quantified. However, the long 
time needed for ELISA and gel electrophoresis 
4. ConcIusions 
With the presented RP-HPLC method a fast 
and reliable tool was developed for the quantita- 
tive determination of human antithrombin III in 
cell culture supernatant and other media includ- 
ing eluates from various purification steps. The 
developed separation procedure on a reversed- 
phase column (C,) allowed also a quantification 
of human transferrin and insulin without any 
changes. 
kD 
96 
67 
43 
Fig. 5. SDS-polyacrylamide gradient gel (S-25%) using a 
modified silver stain under unrcdured conditions. Lanes: 
1 = marker, M, = 14 000-96 000 (reduced) (kDa = 
kilodalton); 2 = clution fraction after membrane ion-cx- 
change step; 3 = clution fraction after affinity chromatog 
raphy; 4 = elution fraction after gel permeation (pure 
rATII1). 
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